89 related articles for article (PubMed ID: 27465571)
1. FACTORS ASSOCIATED WITH PENTOSIDINE ACCUMULATION IN THE HUMAN VITREOUS.
van Deemter M; Bank RA; Vehof J; Hooymans JM; Los LI
Retina; 2017 Apr; 37(4):770-777. PubMed ID: 27465571
[TBL] [Abstract][Full Text] [Related]
2. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
[TBL] [Abstract][Full Text] [Related]
3. Pentosidine accumulates in the aging vitreous body: a gender effect.
van Deemter M; Ponsioen TL; Bank RA; Snabel JM; van der Worp RJ; Hooymans JM; Los LI
Exp Eye Res; 2009 Jun; 88(6):1043-50. PubMed ID: 19450456
[TBL] [Abstract][Full Text] [Related]
4. Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
Fokkens BT; Mulder DJ; Schalkwijk CG; Scheijen JL; Smit AJ; Los LI
PLoS One; 2017; 12(3):e0173379. PubMed ID: 28264049
[TBL] [Abstract][Full Text] [Related]
5. Levels of mature cross-links and advanced glycation end product cross-links in human vitreous.
Matsumoto Y; Takahashi M; Chikuda M; Arai K
Jpn J Ophthalmol; 2002; 46(5):510-7. PubMed ID: 12457909
[TBL] [Abstract][Full Text] [Related]
6. Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy.
Matsumoto Y; Takahashi M; Ogata M
Jpn J Ophthalmol; 2002; 46(4):406-12. PubMed ID: 12225819
[TBL] [Abstract][Full Text] [Related]
7. [Levels of mature cross-links and advanced glycation end product cross-links in human vitreous].
Matsumoto Y; Takahashi M; Chikuda M; Arai K
Nippon Ganka Gakkai Zasshi; 2002 Jan; 106(1):9-15. PubMed ID: 11828768
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of inflammatory immune mediators in vitreous from pseudophakic eyes.
Jakobsson G; Sundelin K; Zetterberg H; Zetterberg M
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3407-14. PubMed ID: 26024125
[TBL] [Abstract][Full Text] [Related]
9. Alterations in human vitreous humour following cataract extraction.
Neal RE; Bettelheim FA; Lin C; Winn KC; Garland DL; Zigler JS
Exp Eye Res; 2005 Mar; 80(3):337-47. PubMed ID: 15721616
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy].
Matsumoto Y; Takahashi M; Ogata M
Nippon Ganka Gakkai Zasshi; 2001 Jul; 105(7):435-41. PubMed ID: 11510106
[TBL] [Abstract][Full Text] [Related]
12. Effect of lens status in the surgical success of 23-gauge primary vitrectomy for the management of rhegmatogenous retinal detachment: the Pan American Collaborative Retina Study (PACORES) group results.
Caiado RR; Magalhães O; Badaró E; Maia A; Novais EA; Stefanini FR; Navarro RM; Arevalo JF; Wu L; Moraes N; Farah ME; Maia M
Retina; 2015 Feb; 35(2):326-33. PubMed ID: 25158939
[TBL] [Abstract][Full Text] [Related]
13. Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole.
Yamamoto N; Ozaki N; Murakami K
Ophthalmologica; 2004; 218(4):248-56. PubMed ID: 15258413
[TBL] [Abstract][Full Text] [Related]
14. POSTERIOR VITREOUS DETACHMENT IN HIGHLY MYOPIC EYES UNDERGOING VITRECTOMY.
Philippakis E; Couturier A; Gaucher D; Gualino V; Massin P; Gaudric A; Tadayoni R
Retina; 2016 Jun; 36(6):1070-5. PubMed ID: 26669837
[TBL] [Abstract][Full Text] [Related]
15. Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.
Nakamura N; Hasegawa G; Obayashi H; Yamazaki M; Ogata M; Nakano K; Yoshikawa T; Watanabe A; Kinoshita S; Fujinami A; Ohta M; Imamura Y; Ikeda T
Diabetes Res Clin Pract; 2003 Aug; 61(2):93-101. PubMed ID: 12951277
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between vascular endothelial growth factors and advanced glycation end products in the human vitreous].
Hashimoto H; Arai K; Chikuda M; Obara Y
Nippon Ganka Gakkai Zasshi; 1998 Jul; 102(7):442-6. PubMed ID: 9720366
[TBL] [Abstract][Full Text] [Related]
17. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
Handa JT; Verzijl N; Matsunaga H; Aotaki-Keen A; Lutty GA; te Koppele JM; Miyata T; Hjelmeland LM
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):775-9. PubMed ID: 10067983
[TBL] [Abstract][Full Text] [Related]
18. Amino-acid levels in subretinal and vitreous fluid of patients with retinal detachment.
Bertram KM; Bula DV; Pulido JS; Shippy SA; Gautam S; Lu MJ; Hatfield RM; Kim JH; Quirk MT; Arroyo JG
Eye (Lond); 2008 Apr; 22(4):582-9. PubMed ID: 17948040
[TBL] [Abstract][Full Text] [Related]
19. Potential roles of pentosidine in age-related and disease-related impairment of pulmonary functions in patients with asthma.
Kanazawa H; Tochino Y; Kyoh S; Ichimaru Y; Asai K; Hirata K
J Allergy Clin Immunol; 2011 Apr; 127(4):899-904. PubMed ID: 21215998
[TBL] [Abstract][Full Text] [Related]
20. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
